Harnessing the Innate Immune System to Target Cancer: A Novel Immunotherapeutic Strategy for Solid Tumours [ 2019 - ]

Research Grant

Researchers: Dr Barbara Rolfe (Principal investigator) ,  A/Pr Trent Woodruff ,  Dr Helga Manthey ,  Dr Lavinia Proctor ,  Prof Andrew Barbour
View all 6 related researchers

Brief description Despite recent improvements in cancer treatments, cancer remains a major cause of death world-wide. This project builds on our recent research demonstrating a novel mechanism by which to 'kick-start' the patient's own immune system to mount an effective anti-cancer response. Specifically we seek to utilise C3aR-targeting antisense oligonucleotides developed by our commercial partner for treatment of advanced cancers that are unresponsive to current immunotherapeutic approaches.

Funding Amount $651,315.00

Funding Scheme Development Grants

Notes Development Grant